These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24440893)

  • 1. Are 2 weeks of "take-home" privileges beneficial for patients' long-term outcome in a methadone maintenance treatment program?
    Adelson M; Schreiber S; Sason A; Peles E
    J Addict Med; 2014; 8(3):170-5. PubMed ID: 24440893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Achievement of take-home dose privileges is associated with better-perceived sleep and with cognitive status among methadone maintenance treatment patients.
    Peles E; Schreiber S; Domany Y; Sason A; Tene O; Adelson M
    World J Biol Psychiatry; 2014 Dec; 15(8):620-8. PubMed ID: 24666249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Earning "take-home" privileges and long-term outcome in a methadone maintenance treatment program.
    Peles E; Schreiber S; Sason A; Adelson M
    J Addict Med; 2011 Jun; 5(2):92-8. PubMed ID: 21769054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low risk for hepatitis C seroconversion in methadone maintenance treatment.
    Peles E; Schreiber S; Rados V; Adelson M
    J Addict Med; 2011 Sep; 5(3):214-20. PubMed ID: 21844836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment outcome unaffected by initiation of full weekend closure of methadone maintenance treatment clinic.
    Peles E; Schreiber S; Adelson M
    J Addict Dis; 2014; 33(2):77-82. PubMed ID: 24717114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive function is largely intact in methadone maintenance treatment patients.
    Elkana O; Adelson M; Doniger GM; Sason A; Peles E
    World J Biol Psychiatry; 2019 Mar; 20(3):219-229. PubMed ID: 28610451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of lifetime psychiatric diagnosis on long-term retention and survival of former opiate addicts in methadone maintenance treatment.
    Peles E; Schreiber S; Domany Y; Adelson M
    World J Biol Psychiatry; 2014 Dec; 15(8):629-35. PubMed ID: 25140586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention.
    White WL; Campbell MD; Spencer RD; Hoffman HA; Crissman B; DuPont RL
    J Psychoactive Drugs; 2014; 46(2):114-22. PubMed ID: 25052787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of methadone maintenance treatment during pregnancy and pregnancy outcome parameters in women with opiate addiction.
    Peles E; Schreiber S; Bloch M; Dollberg S; Adelson M
    J Addict Med; 2012 Mar; 6(1):18-23. PubMed ID: 21817914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel.
    Peles E; Schreiber S; Adelson M
    Drug Alcohol Depend; 2010 Mar; 107(2-3):141-8. PubMed ID: 19914783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study of QTc changes among former opiate addicts since admission to methadone maintenance treatment: benzodiazepine risk.
    Peles E; Linzy S; Kreek MJ; Adelson M
    J Addict Med; 2013; 7(6):428-34. PubMed ID: 24145160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of benzodiazepine use on methadone maintenance treatment outcomes.
    Brands B; Blake J; Marsh DC; Sproule B; Jeyapalan R; Li S
    J Addict Dis; 2008; 27(3):37-48. PubMed ID: 18956528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methadone dose, take home status, and hospital admission among methadone maintenance patients.
    Walley AY; Cheng DM; Pierce CE; Chen C; Filippell T; Samet JH; Alford DP
    J Addict Med; 2012 Sep; 6(3):186-90. PubMed ID: 22694929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to first treatment interruption in the Chinese methadone maintenance treatment programme.
    Sullivan SG; Wu Z; Detels R;
    Drug Alcohol Depend; 2013 Dec; 133(2):427-32. PubMed ID: 23896308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient satisfaction with methadone maintenance treatment: the relevance of participation in treatment and social functioning.
    Trujols J; Garijo I; Siñol N; del Pozo J; Portella MJ; Pérez de los Cobos J
    Drug Alcohol Depend; 2012 Jun; 123(1-3):41-7. PubMed ID: 22071121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The first 38 methadone maintenance treatment patients in Stockholm: 15-year follow-up with a main focus on detoxification from methadone.
    Hiltunen AJ; Eklund C; Borg S
    Nord J Psychiatry; 2011 Apr; 65(2):106-11. PubMed ID: 20662685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SUMMIT trial: a field comparison of buprenorphine versus methadone maintenance treatment.
    Pinto H; Maskrey V; Swift L; Rumball D; Wagle A; Holland R
    J Subst Abuse Treat; 2010 Dec; 39(4):340-52. PubMed ID: 20817384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
    Gerra G; Saenz E; Busse A; Maremmani I; Ciccocioppo R; Zaimovic A; Gerra ML; Amore M; Manfredini M; Donnini C; Somaini L
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):483-9. PubMed ID: 21147192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opiate-dependent patients receiving methadone. How physicians should manage therapy.
    Kahan M; Sutton N
    Can Fam Physician; 1996 Sep; 42():1769-78. PubMed ID: 8828879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence.
    Karow A; Reimer J; Schäfer I; Krausz M; Haasen C; Verthein U
    Drug Alcohol Depend; 2010 Dec; 112(3):209-15. PubMed ID: 20728288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.